The inhibition of IRE1α-mediated cleavage of mRNAs encoding the invasion marker SPARC and other ECM candidate targets [9, 18], as well as of microRNAs [40] functionally associated to tumor invasiveness [41–43], could participate to this phenotypic switch. The gene discussed is SPARC; the disease is neoplasm.